Han Liu

Advancing anticancer dose selection and individualization

Liu, Han

2026

• Ladda ner fulltext (pdf) av Advancing anticancer dose selection and individualization

Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Liu, Han; Ibrahim, Eman I.K.; Centanni, Maddalena; Sarr, Céline et al.

Ingår i Advanced Drug Delivery Reviews, 2025

• DOI för Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
• Ladda ner fulltext (pdf) av Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Multistate modeling for survival analysis in critically ill patients treated with meropenem

Peng, Yaru; Minichmayr, Iris; Liu, Han; Xie, Feifan et al.

Ingår i CPT, s. 222-233, 2024

• DOI för Multistate modeling for survival analysis in critically ill patients treated with meropenem
• Ladda ner fulltext (pdf) av Multistate modeling for survival analysis in critically ill patients treated with meropenem

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer

Liu, Han; Milenković‐Grišić, Ana‐Marija; Krishnan, Sreenath M.; Jönsson, Siv et al.

Ingår i CPT, s. 1738-1750, 2023

• DOI för A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer
• Ladda ner fulltext (pdf) av A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.

Liu, Han; Milenković-Grišić, Ana-Marija; Madathil Krishnan, Sreenath; Jönsson, Siv et al.

Ingår i CPT, s. 1738-1750, 2023

• DOI för A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.

Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Liu, Han; Ibrahim, Eman I.K.; Centanni, Maddalena; Sarr, Céline et al.

Ingår i Advanced Drug Delivery Reviews, 2025

• DOI för Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
• Ladda ner fulltext (pdf) av Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Multistate modeling for survival analysis in critically ill patients treated with meropenem

Peng, Yaru; Minichmayr, Iris; Liu, Han; Xie, Feifan et al.

Ingår i CPT, s. 222-233, 2024

• DOI för Multistate modeling for survival analysis in critically ill patients treated with meropenem
• Ladda ner fulltext (pdf) av Multistate modeling for survival analysis in critically ill patients treated with meropenem

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer

Liu, Han; Milenković‐Grišić, Ana‐Marija; Krishnan, Sreenath M.; Jönsson, Siv et al.

Ingår i CPT, s. 1738-1750, 2023

• DOI för A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer
• Ladda ner fulltext (pdf) av A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.

Liu, Han; Milenković-Grišić, Ana-Marija; Madathil Krishnan, Sreenath; Jönsson, Siv et al.

Ingår i CPT, s. 1738-1750, 2023

• DOI för A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.

Advancing anticancer dose selection and individualization

Liu, Han

2026

• Ladda ner fulltext (pdf) av Advancing anticancer dose selection and individualization

Time-related bias and confounding bias in toxicity-survival associations for antiCancer drugs

Liu, Han; Friberg, Lena E.

Bias in exposure-response analysis of sunitinib in renal cancer

Liu, Han; Friberg, Lena E.

Sex differences in sunitinib tolerability and patient-reported outcomes in metastatic renal cell carcinoma: the role of exposure and implications for precision dosing

Liu, Han; Friberg, Lena E.